These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9147754)
1. [Treatment of autoimmune neuromuscular diseases with intravenous immunoglobulins]. Illa I; Serrano C; Prat C Rev Neurol; 1997 Feb; 25(138):263-6. PubMed ID: 9147754 [No Abstract] [Full Text] [Related]
2. Intravenous immune globulin in neuromuscular disorders. Gupta S West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991 [No Abstract] [Full Text] [Related]
3. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Dalakas MC Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245 [TBL] [Abstract][Full Text] [Related]
4. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases]. Molnár MJ Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454 [TBL] [Abstract][Full Text] [Related]
5. Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG). Maetzke J; Sperfeld AD; Scharffetter-Kochanek K; Sunderkötter C Allergy; 2006 Jan; 61(1):145-6. PubMed ID: 16364173 [No Abstract] [Full Text] [Related]
6. The use of intravenous immunoglobulins in the treatment of neuromuscular disorders. Voltz R; Hohlfeld R Curr Opin Neurol; 1996 Oct; 9(5):360-6. PubMed ID: 8894412 [TBL] [Abstract][Full Text] [Related]
7. Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies. Souza PV; Pinto WB; Oliveira AS Arq Neuropsiquiatr; 2014 Dec; 72(12):966-71. PubMed ID: 25465778 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin and quality of life. Padua L; Aprile I; Caliandro P; Pazzaglia C; Tonali P JAMA; 2004 Sep; 292(12):1429; author reply 1429-30. PubMed ID: 15383509 [No Abstract] [Full Text] [Related]
9. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases. Gomperts ED; Darr F Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310 [No Abstract] [Full Text] [Related]
14. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Sapir T; Blank M; Shoenfeld Y Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases. Rütter A; Luger TA Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544 [TBL] [Abstract][Full Text] [Related]
16. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins. Mehta YS; Badakere SS J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299 [TBL] [Abstract][Full Text] [Related]
17. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives]. Wintzell A; Eriksson T; Lundgren A; Petersson J Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994 [No Abstract] [Full Text] [Related]
18. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis]. Cherin P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life. Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706 [TBL] [Abstract][Full Text] [Related]